Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
Publication of Interim Results and Presentation at Recent Industry Event Demonstrate Clinical Benefit Associated with Use of ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
Penumbra, Inc. (NYSE: PEN) announced additional results of the ground-breaking STORM-PE randomized controlled trial (RCT), ...
MedPage Today on MSN
Rapid-Acting Drug for Major Heart Attacks Hits Main Goal in Trial
NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single ...
Sequencing of Endocrine and Targeted Therapies in Hormone-Sensitive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer A key but often overlooked question in oncology clinical ...
Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development for the treatment of ...
Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an important component of the comprehensive response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...
Orpyx® Medical Technologies announced today that its sensory insoles, analytics platform, and remote monitoring program will ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback